| 000 | 01562 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512075149.0 | ||
| 264 | 0 | _c19860108 | |
| 008 | 198601s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1985.tb27096.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColeman, M S | |
| 245 | 0 | 0 |
_aAdenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _c1985 |
||
| 300 |
_a54-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenosine Deaminase _xdeficiency |
| 650 | 0 | 4 | _aAdenosine Deaminase Inhibitors |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCoformycin _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xenzymology |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xmetabolism |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLymphocytes _xenzymology |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNucleoside Deaminases _xdeficiency |
| 650 | 0 | 4 | _aPentostatin |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 700 | 1 | _aDanton, M J | |
| 700 | 1 | _aPhilips, A | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 451 _gp. 54-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1985.tb27096.x _zAvailable from publisher's website |
| 999 |
_c3883811 _d3883811 |
||